BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31652123)

  • 1. A multi-institutional analysis of diffuse large B-cell lymphoma (DLBCL) treated with consolidative radiotherapy and the impact of cell-of-origin on outcomes.
    Rajasooriyar C; Tey J; Wong LC; Poon M; Nandini R; Tham I; Vellayappan B
    Radiol Oncol; 2019 Oct; 53(4):473-479. PubMed ID: 31652123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy.
    Shi Z; Das S; Okwan-Duodu D; Esiashvili N; Flowers C; Chen Z; Wang X; Jiang K; Nastoupil LJ; Khan MK
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):569-77. PubMed ID: 23540349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
    Jegadeesh N; Rajpara R; Esiashvili N; Shi Z; Liu Y; Okwan-Duodu D; Flowers CR; Khan MK
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):107-12. PubMed ID: 25863758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I-II diffuse large B-cell lymphoma (KROG 17-02).
    Chung MJ; Cho WK; Oh D; Eom KY; Kim JH; Kim WC; Lee JH
    J Radiat Res; 2019 Oct; 60(5):677-684. PubMed ID: 31251343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
    J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Radiotherapy in Early-stage Primary Diffuse Large B-Cell Lymphoma of the Waldeyer Ring: A Retrospective Cohort Study.
    Lee SF; Ng TY; Wong FCS; Tung SY
    Am J Clin Oncol; 2018 Aug; 41(8):802-806. PubMed ID: 28263229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of bulky mass and residual tumor-Treated with or without consolidative radiotherapy-To the risk of relapse in DLBCL patients.
    Tokola S; Kuitunen H; Turpeenniemi-Hujanen T; Kuittinen O
    Cancer Med; 2020 Mar; 9(6):1966-1977. PubMed ID: 31967739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy.
    Holzhäuser E; Berlin M; Wollschläger D; Bezold T; Mayer A; Heß G; Schmidberger H
    Strahlenther Onkol; 2017 Dec; 193(12):1014-1023. PubMed ID: 28748453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era.
    Kumar A; Lunning MA; Zhang Z; Migliacci JC; Moskowitz CH; Zelenetz AD
    Br J Haematol; 2015 Dec; 171(5):776-83. PubMed ID: 26456939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
    Vargo JA; Gill BS; Balasubramani GK; Beriwal S
    J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).
    Bruno Ventre M; Ferreri AJ; Gospodarowicz M; Govi S; Messina C; Porter D; Radford J; Heo DS; Park Y; Martinelli G; Taylor E; Lucraft H; Hong A; Scarfò L; Zucca E; Christie D;
    Oncologist; 2014 Mar; 19(3):291-8. PubMed ID: 24567283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidative Radiotherapy After Autologous Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B-cell Lymphoma.
    Coutu BG; Wilke CT; Yuan J; Cao Q; Vernon MR; Lee C; Bachanova V; Dusenbery KE
    Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):65-73. PubMed ID: 29079283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission.
    Li Q; Li W; Wang L; Wang W; Niu S; Bi X; Wang H; Zhang Y
    PLoS One; 2015; 10(7):e0133469. PubMed ID: 26193661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
    Laskar S; Bahl G; Muckaden MA; Nair R; Gupta S; Bakshi A; Gujral S; Shet T; Shrivastava SK; Dinshaw KA
    Cancer; 2007 Aug; 110(4):816-23. PubMed ID: 17582622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy.
    Mian M; Ferreri AJ; Rossi A; Conconi A; Tsang R; Gospodarowicz MK; Oldani E; Federico M; Luminari S; Pogliani EM; Rossini F; Cabrera ME; Martelli M; Gutierrez-Garcia G; Busetto M; Cavalli F; Zucca E; Rambaldi A; Cortelazzo S;
    Leuk Lymphoma; 2013 Jan; 54(1):62-8. PubMed ID: 22784364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HIV infection on consolidative radiotherapy for non-Hodgkin diffuse large B-cell lymphoma.
    Medici CTM; Mauro GP; Casimiro LC; Weltman E
    Radiat Oncol; 2020 Jun; 15(1):153. PubMed ID: 32539797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma.
    Kwon J; Kim IH; Kim BH; Kim TM; Heo DS
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):91-8. PubMed ID: 25721091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era.
    Cassidy RJ; Jegadeesh N; Switchenko J; Danish H; Esiashvili N; Flowers CR; Khan MK
    Leuk Lymphoma; 2016 Aug; 57(8):1876-82. PubMed ID: 26759182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
    Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.